Sinovac Biotech Ltd (NASDAQ:SVA)

--
Delayed Data
As of --
-- -- / --
Today’s Change
--
|||52-Week Range
--
--
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 2
2016
Quarter 3
2016
Quarter 4
2016
Quarter 1
2019
Revenue and IncomeNet Revenues1.4M28.7M31.4M36.6M
 
 
 
 
 
Cost of Goods Sold2.3M4.5M7.4M2.7M
 
 
 
 
 
Depreciation And Amortization1.4M1.2M966.0K1.0M
 
 
 
 
 
 
Operating ExpensesGross Income-2.4M23.0M23.0M32.8M
 
 
 
 
 
General Expenses11.4M17.0M19.2M27.8M
 
 
 
 
 
Research And Development2.8M4.2M3.6M4.5M
 
 
 
 
 
Total Operating Expenses15.1M22.7M27.5M31.6M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-13.7M6.0M3.9M5.0M
 
 
 
 
 
Interest Expense On Debt401.0K352.0K593.0K178.0K
 
 
 
 
 
Other Expenses-47.0K-1.0K6.0M146.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-14.0M5.8M9.4M5.2M
 
 
 
 
 
Income Taxes-1.4M-1.5M-2.6M-1.6M
 
 
 
 
 
Minority Interest-3.0M-1.1M-2.4M-1.8M
 
 
 
 
 
Preferred Dividend0.000.000.00-608.0K
 
 
Net Income-9.6M3.2M4.4M1.8M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS56.9M57.0M57.0M82.6M
 
 
 
 
 
Shares To Calculate EPS Diluted56.9M57.0M57.0M82.7M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.17$0.06$0.08$0.01
 
 
 
 
 
EPS Diluted-$0.17$0.06$0.08$0.01